SHAYYAMUTRA & its management and prevention

A STUDY ON THE EFFICACY OF ASVAGHANDHADI COMPOUND (ANUBHUT) IN THE MANAGMENT OF SHAYYAMUTRA

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/04/008440

Enrollment

Registered

2017-04-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- SHAYYAMUTRA

Interventions

Intervention1: PLACEBO CAPSULE WITH MEDICAL COUNSELLING: 1 CAP EACH OF 250 MG TWICE DAILY FOR 60 DAYS AS TREATMENT GROUP Intervention2: ASVAGHANDHADI COMPOUND: 2 TAB EACH OF 500 MG TWICE DAILY FOR 60

Eligibility

Inclusion criteria

Inclusion criteria: cardinal features of shayyamutra without daytime incontinance,repeated voiding of urinein bed or clothes at least 2-3 times in a week

Exclusion criteria

Exclusion criteria: disorders like TB,DM,urinary tract infection ,congenital anomalies,anatomical defect of genitourinary system,neurological disorders like cerebral palsy,mental retardation,spina bifida

Design outcomes

Primary

Measure	Time frame
Asvaghandhadi Compound is more effective than Brahmi Vati & placebo groupTimepoint: Asvaghandhadi Compound is more effective than Brahmi Vati & placebo group	—

Secondary

Measure	Time frame
Bedwetting controlledTimepoint: Till Present study	—

Countries

India

Contacts

Public ContactDR SUNIL P CHANGLE

parul institute of ayurved

sunilchangle16@gmail.com9687613916

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026